ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Haier Biomedical Cold Room Safeguards Uganda’s Vaccine Safety

Under the efforts of all the parties involved, Haier Biomedical's Uganda Cold Room Project was successfully delivered at the end of April, becoming the largest national cold room that can safeguard vaccine safety effectively. As the global vaccine safety solution manufacturer and provider, Haier Biomedical strives to be the most reliable vaccine guardian, to make life better through the intelligent protection of life science.

Under the impetus of the increasing population and vaccine introduction, the quantity of vaccines in Uganda has increased rapidly. The previous small standard cold room at the former site of NMS can no longer meet the vaccine storage needs due to the small volume and low space utilization. However, once any safety problem occurs due to improper vaccine storage, the consequences will be unbearable.

Upon repeated discussion, the Ministry of Health, Uganda determined to reconstruct the NMS Storage for an improved central vaccine storage capacity. Therefore, it requested the United Nations International Children’s Emergency Fund for help in purchasing and installing larger and more efficient vaccine storage facilities, including 7 large-scale cold rooms (367m³ each), 2 freezer rooms (40m³ each), and 1 cool room (about 1500m³). After several rounds of comprehensive bidding and evaluation, Haier Biomedical was selected to be the supplier of the customized equipment and services.

As a WHO PQS-certified cold chain solution supplier, Haier Biomedical is always committed to providing optimal cold chain storage solutions for all users. Based on the bidding requirements and the field investigation, Haier Biomedical tailored a complete cold storage solution for Uganda. Considering the large floor space, high labor costs, and other associated problems, the cold rooms select PLC to be the control system to automatically control the start/stop of the refrigerating units to ensure scheduled switching between the host and the standby and automatic switching in the case of any failure, thus significantly reducing the running risk. Designed with an efficient refrigeration system, the cold storage can achieve accurate temperature control and guaranteed temperature uniformity and stability. Its LORA remote temperature monitoring device enables the user to understand the temperature and humidity changes in real time. At the same time, featuring functions such as fault self-diagnosis, active protection, sound and light alarm, and SMS early warning, the equipment can have the running status monitored to ensure the secure storage of samples.

Furthermore, Haier Biomedical Cold Rooms have also solved a big problem for the Ugandan Government. The cold rooms used in the past had high energy consumption and a high risk of pollution, while Haier Biomedical Cold Room, through the use of the R448a environmentally friendly refrigerant and green and durable PU insulation boards, has minimal ozone depletion potential and excellent insulation performance. In addition, with the defrosting water overcooling and exhaust air pre-cooling technologies, the room can protect the environment and save energy effectively.

Under the efforts of all the parties involved, Haier Biomedical's Uganda Cold Room Project was successfully delivered at the end of April, becoming the largest national cold room that can safeguard vaccine safety effectively.

As the global vaccine safety solution manufacturer and provider, Haier Biomedical strives to be the most reliable vaccine guardian, to make life better through the intelligent protection of life science.

Media Contact
Company Name: Haier Biomedical
Email: Send Email
Phone: +86-532-88935593
Country: China
Website: https://www.haiermedical.com/


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.